It has been shown that cancer cells are able to survive against oxidative stress by activating Nrf2 constitutively, and in this way upregulating the antioxidant response in different types of tumors (lung, pancreas, breast, and endometrium), with increased tumor aggression and resistance to chemotherapy [18,19]. This evidence concerns the gene NFE2L2 and cancer.